Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.
Authors
Shaw, Bronwen EApperley, Jane F
Russell, Nigel
Craddock, Charles
Liakopoulou, Effie F
Potter, Mike N
Wynn, Robert F
Gibson, Brenda E
Pearce, Rachel M
Kirkland, Keiren E
Lee, Julia
Madrigal, J Alejandro
Cook, Gordon
Byrne, Jennifer L
Affiliation
Anthony Nolan Trust, LondonIssue Date
2011
Metadata
Show full item recordCitation
Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo Alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease. 2011, 153 (2):244 Br J HaematolJournal
British Journal of HaematologyDOI
10.1111/j.1365-2141.2011.08615.xPubMed ID
21382020Type
ArticleLanguage
enISSN
00071048ae974a485f413a2113503eed53cd6c53
10.1111/j.1365-2141.2011.08615.x